Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Knopp Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Knopp Biosciences

Knopp Biosciences

Series C

Knopp Biosciences, a US-based company, innovates breakthrough neurological disorder treatments, with a lead compound in development.

HQ
Pittsburgh, PA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Knopp Biosciences is a drug discovery and development company based in Pittsburgh, United States, focused on delivering breakthrough treatments for neurological disorders. The company leverages innovation, experience, and partnerships to advance its mission. Knopp’s lead compound, KNS-760704, is in clinical development, and the company also manages a portfolio of equity securities and future product royalties. Their clinical-stage oral small molecule, dexpramipexole, is being developed for eosinophilic asthma by Areteia Therapeutics.

Knopp Biosciences has made significant strides in the field of drug discovery, particularly in challenging immunological and neurological diseases. Their Kv7 platform of small molecules is in the clinical stage, showcasing their commitment to advancing medical science. Notably, Areteia Therapeutics, a portfolio company of Bain Capital Life Sciences, is developing one of Knopp’s compounds, highlighting the company's impactful collaborations and contributions to innovative healthcare solutions.

Knopp Biosciences - Similar Companies

KBP Biosciences logo

KBP Biosciences

kbpbiosciences.com

Caden Biosciences logo

Caden Biosciences

Bioscience Pharma Partners logo

Bioscience Pharma Partners

Harmony Biosciences logo

Harmony Biosciences

Know Bio logo

Know Bio

knowbiollc.com

NeurOp logo

NeurOp

Escape Bio logo

Escape Bio

escapebio.com

ReNeuroGen logo

ReNeuroGen

rngen.com

Areteia Therapeutics logo

Areteia Therapeutics

areteiatx.com

Nido Biosciences logo

Nido Biosciences

nidobio.com

Neuropathix logo

Neuropathix

neuropathix.com

Intellect Neurosciences logo

Intellect Neurosciences

Aptinyx logo

Aptinyx

aptinyx.com

Kezar Life Sciences logo

Kezar Life Sciences

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Knopp Biosciences - Quick Facts

Who are Knopp Biosciences' competitors?

Companies similar to Knopp Biosciences include KBP Biosciences, Caden Biosciences, Bioscience Pharma Partners and Harmony Biosciences.

When was Knopp Biosciences founded?

Knopp Biosciences was founded in 2004.

Where is Knopp Biosciences' headquarters located?

Knopp Biosciences' headquarters is located in Pittsburgh, PA, US.

When was Knopp Biosciences' last funding round?

Knopp Biosciences' most recent funding round was for $14M (USD) in November 2020.

How much has Knopp Biosciences raised to-date?

As of Nov 11, 2020, Knopp Biosciences has raised a total of $164M (USD).

How many employees does Knopp Biosciences have?

Knopp Biosciences has 10 employees as of Feb 5, 2024.

Knopp Biosciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified